HINDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Vyome Holdings, Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$1.84−0.03 (-1.60%)
Close on Oct 19, 2026
- Market cap
- $12.91M
- P/E (TTM)
- –
- Dividend yield
- –
Vyome statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Vyome | Industry median |
|---|---|---|
| Market Cap | $12.91M | $164.85M |
| Enterprise Value | $6.29M | $87.06M |
| PS Ratio | 99.55 | 3.60 |
Enterprise value
| Measure | Vyome | Industry median |
|---|---|---|
| EV / Sales | 48.49 | 2.43 |
Income (trailing twelve months)
| Measure | Vyome | Industry median |
|---|---|---|
| Revenue | $129.72K | $57.94M |
| Gross Profit | $68.42K | $90.47M |
| Operating Income | -$11.92M | -$21.44M |
| Net Income | -$11.31M | -$22.46M |
| EBITDA | -$11.91M | -$16.91M |
Margins
| Measure | Vyome | Industry median |
|---|---|---|
| Gross Margin | 52.7% | 52.3% |
| Operating Margin | -9190.2% | -44.5% |
| Profit Margin | -8716.8% | -39.2% |
| EBITDA Margin | -9181.9% | -31.3% |
Returns
| Measure | Vyome | Industry median |
|---|---|---|
| Return on Equity (ROE) | -194.0% | -53.1% |
| Return on Assets (ROA) | -124.2% | -41.0% |
| Return on Invested Capital (ROIC) | -173.0% | -32.0% |
| Return on Capital Employed (ROCE) | -163.1% | -37.8% |
Growth
| Measure | Vyome | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -67.1% | 6.01% |
| Revenue Growth (3Y CAGR) | -69.5% | 2.25% |
| Revenue Growth (5Y CAGR) | -51.0% | 6.42% |
Balance sheet
| Measure | Vyome | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $7.89M | $62.42M |
| Net Cash (Debt) | $7.89M | $15.68M |
| Net Cash Per Share | $1.12 | $0.66 |
| Working Capital | $6.29M | $75.77M |
Financial position
| Measure | Vyome | Industry median |
|---|---|---|
| Current Ratio | 4.37 | 3.30 |
| Quick Ratio | 4.23 | 2.39 |
| Interest Coverage | -285.77 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Vyome | Industry median |
|---|---|---|
| Operating Cash Flow | -$5.58M | -$12.35M |
Efficiency
| Measure | Vyome | Industry median |
|---|---|---|
| Asset Turnover | 0.01 | 0.38 |
| Inventory Turnover | 0.02 | 2.67 |
| Revenue Per Employee | $7.21K | $398.96K |
| Profits Per Employee | -$628.21K | -$703.34K |
| Employee Count | 18 | 74 |
Dividends and yields
| Measure | Vyome | Industry median |
|---|---|---|
| Earnings Yield | -87.6% | -22.7% |
| Buyback Yield | 33.2% | -0.73% |
| Shareholder Yield | 33.2% | 0.00% |
Shares
| Measure | Vyome | Industry median |
|---|---|---|
| Shares Outstanding | 7,018,530 | 58,179,650 |
| Shares Change (QoQ) | 0.00% | 0.54% |
| Float | 6,538,020 | 49,173,100 |
| Shares Held by Insiders | 6.85% | 11.6% |
| Shares Held by Institutions | 1.97% | 59.4% |
Scores
| Measure | Vyome | Industry median |
|---|---|---|
| Altman Z-Score | -12.91 | -0.24 |
| Piotroski F-Score | 4 | 4 |
| Beneish M-Score | -8.07 | -2.62 |
Calculated by StockData from Vyome's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.